Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.38)
# 943
Out of 4,955 analysts
516
Total ratings
39.96%
Success rate
5.91%
Average return
Main Sectors:
Stocks Rated by Yi Chen
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
LPCN Lipocine | Reiterates: Buy | $8 | $3.01 | +165.78% | 4 | Aug 20, 2025 | |
RGNX REGENXBIO | Reiterates: Buy | $34 | $8.11 | +319.24% | 11 | Aug 19, 2025 | |
BNGO Bionano Genomics | Maintains: Buy | $10 → $11 | $4.13 | +166.34% | 2 | Aug 18, 2025 | |
SMTI Sanara MedTech | Maintains: Buy | $53 → $54 | $30.52 | +76.93% | 5 | Aug 18, 2025 | |
ICCM IceCure Medical | Maintains: Buy | $2.5 → $2 | $0.88 | +128.41% | 22 | Aug 15, 2025 | |
HROW Harrow | Maintains: Buy | $60 → $64 | $38.16 | +67.71% | 5 | Aug 13, 2025 | |
SRTS Sensus Healthcare | Maintains: Buy | $12 → $8 | $3.27 | +144.65% | 20 | Aug 12, 2025 | |
BLFS BioLife Solutions | Maintains: Buy | $30 → $32 | $25.11 | +27.44% | 3 | Aug 8, 2025 | |
LFMD LifeMD | Maintains: Buy | $14 → $13 | $6.29 | +106.68% | 10 | Aug 7, 2025 | |
EYPT EyePoint Pharmaceuticals | Maintains: Buy | $22 → $23 | $11.60 | +98.28% | 23 | Aug 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.53 | - | 24 | Aug 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $14.50 | +10.34% | 19 | Jul 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $0.79 | +408.97% | 7 | Jul 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $5 | $0.40 | +1,140.69% | 22 | Jul 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $9.07 | +76.41% | 11 | Jul 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $66.29 | +50.85% | 20 | Jul 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5 | $2.38 | +110.08% | 1 | Jun 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $2.56 | +251.56% | 1 | Jun 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $12.13 | +23.71% | 27 | May 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $8.62 | +108.82% | 1 | May 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $12 | $8.50 | +41.18% | 22 | May 23, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.22 | +229.22% | 6 | May 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $12.51 | +99.84% | 12 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.35 | +197.87% | 13 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $23.06 | +116.83% | 7 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $3.14 | +186.62% | 18 | Apr 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $39 | $11.85 | +229.11% | 8 | Apr 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $32 | $17.80 | +79.78% | 14 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $0.68 | +267.11% | 2 | Apr 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.38 | +117.39% | 14 | Apr 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $2.49 | +381.93% | 4 | Apr 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.74 | +304.75% | 1 | Mar 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $0.31 | +225.84% | 23 | Mar 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.62 | +281.68% | 16 | Mar 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.95 | +137.29% | 19 | Mar 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.19 | +153.16% | 13 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.55 | +745.07% | 20 | Jan 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.76 | - | 10 | Nov 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5,250 → $1,125 | $3.52 | +31,860.23% | 18 | Jun 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.14 | +6,854.10% | 5 | May 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.34 | +3,182.60% | 14 | Feb 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.64 | - | 7 | Jun 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $13.90 | +245.32% | 8 | Apr 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $50.38 | -62.29% | 2 | Feb 17, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.08 | - | 2 | Apr 16, 2020 |
Lipocine
Aug 20, 2025
Reiterates: Buy
Price Target: $8
Current: $3.01
Upside: +165.78%
REGENXBIO
Aug 19, 2025
Reiterates: Buy
Price Target: $34
Current: $8.11
Upside: +319.24%
Bionano Genomics
Aug 18, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $4.13
Upside: +166.34%
Sanara MedTech
Aug 18, 2025
Maintains: Buy
Price Target: $53 → $54
Current: $30.52
Upside: +76.93%
IceCure Medical
Aug 15, 2025
Maintains: Buy
Price Target: $2.5 → $2
Current: $0.88
Upside: +128.41%
Harrow
Aug 13, 2025
Maintains: Buy
Price Target: $60 → $64
Current: $38.16
Upside: +67.71%
Sensus Healthcare
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $3.27
Upside: +144.65%
BioLife Solutions
Aug 8, 2025
Maintains: Buy
Price Target: $30 → $32
Current: $25.11
Upside: +27.44%
LifeMD
Aug 7, 2025
Maintains: Buy
Price Target: $14 → $13
Current: $6.29
Upside: +106.68%
EyePoint Pharmaceuticals
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $11.60
Upside: +98.28%
Aug 1, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.53
Upside: -
Jul 31, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $14.50
Upside: +10.34%
Jul 29, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.79
Upside: +408.97%
Jul 18, 2025
Downgrades: Neutral
Price Target: $5
Current: $0.40
Upside: +1,140.69%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $9.07
Upside: +76.41%
Jul 3, 2025
Reiterates: Buy
Price Target: $100
Current: $66.29
Upside: +50.85%
Jun 27, 2025
Assumes: Buy
Price Target: $5
Current: $2.38
Upside: +110.08%
Jun 18, 2025
Assumes: Buy
Price Target: $9
Current: $2.56
Upside: +251.56%
May 29, 2025
Reiterates: Buy
Price Target: $15
Current: $12.13
Upside: +23.71%
May 28, 2025
Initiates: Buy
Price Target: $18
Current: $8.62
Upside: +108.82%
May 23, 2025
Maintains: Buy
Price Target: $15 → $12
Current: $8.50
Upside: +41.18%
May 19, 2025
Reiterates: Buy
Price Target: $4
Current: $1.22
Upside: +229.22%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $12.51
Upside: +99.84%
May 5, 2025
Reiterates: Buy
Price Target: $7
Current: $2.35
Upside: +197.87%
May 5, 2025
Reiterates: Buy
Price Target: $50
Current: $23.06
Upside: +116.83%
Apr 29, 2025
Reiterates: Buy
Price Target: $9
Current: $3.14
Upside: +186.62%
Apr 21, 2025
Maintains: Buy
Price Target: $38 → $39
Current: $11.85
Upside: +229.11%
Apr 17, 2025
Maintains: Buy
Price Target: $29 → $32
Current: $17.80
Upside: +79.78%
Apr 11, 2025
Reiterates: Buy
Price Target: $2.5
Current: $0.68
Upside: +267.11%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.38
Upside: +117.39%
Apr 4, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $2.49
Upside: +381.93%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $0.74
Upside: +304.75%
Mar 28, 2025
Maintains: Neutral
Price Target: $1.5 → $1
Current: $0.31
Upside: +225.84%
Mar 28, 2025
Reiterates: Buy
Price Target: $10
Current: $2.62
Upside: +281.68%
Mar 25, 2025
Reiterates: Buy
Price Target: $7
Current: $2.95
Upside: +137.29%
Mar 21, 2025
Reiterates: Buy
Price Target: $3
Current: $1.19
Upside: +153.16%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $3.55
Upside: +745.07%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.76
Upside: -
Jun 10, 2024
Maintains: Buy
Price Target: $5,250 → $1,125
Current: $3.52
Upside: +31,860.23%
May 17, 2024
Reiterates: Buy
Price Target: $10
Current: $0.14
Upside: +6,854.10%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.34
Upside: +3,182.60%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.64
Upside: -
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $13.90
Upside: +245.32%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $50.38
Upside: -62.29%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.08
Upside: -